- Lobbying
- Lobbying by Roche Diagnostics
Lobbying Relationship
Bills mentioned
H.R.3271: Protecting Access to Diabetes Supplies Act of 2017
Sponsor: Diana DeGette (D-Colo.)
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
H.R.771: Protecting Access to Diabetes Supplies Act of 2015
Sponsor: Diana DeGette (D-Colo.)
H.R.3303: SOFTWARE Act of 2013
Sponsor: Marsha Blackburn (R-Tenn.)
H.R.2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Sponsor: Peter Roskam (R-Ill.)
H.R.1936: Medicare Access to Diabetes Supplies Act of 2011
Sponsor: Aaron Schock (R-Ill.)
S.3187: Food and Drug Administration Safety and Innovation Act
Sponsor: Tom Harkin (D-Iowa)
H.R.3584: Laboratory Access for Beneficiaries Act
Sponsor: Scott Peters (D-Calif.)
H.R.747: Access to TESTs Act
Sponsor: Diana DeGette (D-Colo.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Donn Salvosa | 94: Staff Asst., Congressman Cliff Stearns 95-2000; Staff Aide & Leg Clerk , House Energy and Commerce 94; Staff Asst., Congressman Cliff Stearns; 95-2000; Staff Aide & Leg Clerk, House Energy and Commerce |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Medicare
U.S. Senate
U.S. Senate
U.S. Senate
Medicare
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate